Jean-Yves Bonnefoy
Fundador en Anagenesis Biotechnologies SAS .
Perfil
Jean-Yves Bonnefoy is the founder of Anagenesis Biotechnologies SAS (2011) where he holds the title of President, Chief Executive Officer & Director.
He is also the founder of ElsaLys Biotech SAS.
Currently, he is the Chairman of Alsace BioValley Association (since 2011), Chairman of Syndivia SAS (since 2013), and Director of Platine Pharma Services SAS.
In the past, he worked as a Director at Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
and as Vice President-Research & Development at Transgene SA. He holds a doctorate degree from the University of Lyon.
Cargos activos de Jean-Yves Bonnefoy
Empresas | Cargo | Inicio |
---|---|---|
Alsace BioValley Association
Alsace BioValley Association Medical/Nursing ServicesHealth Services Alsace BioValley Association operates as a health innovation center. The private company is based in Illkirch, France. | Presidente | 01/01/2011 |
Platine Pharma Services SAS
Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Based in Lyon within the Center of excellence in Infectious Diseases, Platine Pharma Services is an essential source of immune information for scientists and clinicians. From protocol support to regulatory reports, the company designs, performs and interprets complex molecular and cellular assays. Platine actively supports the development of in-vitro diagnostic, cosmetic and therapeutic product candidates, highlighting key markers and features in both normal and pathological conditions, and guiding decisions at each development stage. Using state-of-the-art technologies such as multi-parametric flow cytometry, Singulex, Luminex, Mesoscale Discovery, ELISpot or ELISA, Platine Pharma Services offers a fit-for-purpose approach to its customers and partners. | Director/Miembro de la Junta | - |
Anagenesis Biotechnologies SAS
Anagenesis Biotechnologies SAS Medical/Nursing ServicesHealth Services Anagenesis Biotechnologies SAS operates as a preclinical-stage stem cell-based company. It focuses on developing novel treatments for genetic and age-related muscle degenerative diseases with unmet medical needs. The firm offers cell therapy for genetic diseases and pharmacological drugs for genetic and age-related diseases. The company was founded by Jean-Yves Bonnefoy, Christopher Henderson, Thierry Noel, Olivier Pourquié, Marie Knockaert and Jérôme Chal on April 25, 2011 and is headquartered in Graffenstaden, France. | Fundador | 25/04/2011 |
Syndivia SAS
Syndivia SAS Pharmaceuticals: MajorHealth Technology Syndivia SAS engages in the development of treatment for cancer. Its product pipeline include SDV1001, for pancreatic cancer, colorectal cancer and TNBC; and SDV1101, for breast cancer and liposarcoma. The company is headquartered in Illkirch, France. | Presidente | 01/04/2013 |
Antiguos cargos conocidos de Jean-Yves Bonnefoy.
Empresas | Cargo | Fin |
---|---|---|
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Director/Miembro de la Junta | - |
ELSALYS BIOTECH | Director Ejecutivo | - |
TRANSGENE | Director Técnico/Científico/I+D | - |
Formación de Jean-Yves Bonnefoy.
University of Lyon | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
TRANSGENE | Health Technology |
Empresas privadas | 6 |
---|---|
Alsace BioValley Association
Alsace BioValley Association Medical/Nursing ServicesHealth Services Alsace BioValley Association operates as a health innovation center. The private company is based in Illkirch, France. | Health Services |
Platine Pharma Services SAS
Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Based in Lyon within the Center of excellence in Infectious Diseases, Platine Pharma Services is an essential source of immune information for scientists and clinicians. From protocol support to regulatory reports, the company designs, performs and interprets complex molecular and cellular assays. Platine actively supports the development of in-vitro diagnostic, cosmetic and therapeutic product candidates, highlighting key markers and features in both normal and pathological conditions, and guiding decisions at each development stage. Using state-of-the-art technologies such as multi-parametric flow cytometry, Singulex, Luminex, Mesoscale Discovery, ELISpot or ELISA, Platine Pharma Services offers a fit-for-purpose approach to its customers and partners. | Health Services |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Commercial Services |
ElsaLys Biotech SAS
ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
Anagenesis Biotechnologies SAS
Anagenesis Biotechnologies SAS Medical/Nursing ServicesHealth Services Anagenesis Biotechnologies SAS operates as a preclinical-stage stem cell-based company. It focuses on developing novel treatments for genetic and age-related muscle degenerative diseases with unmet medical needs. The firm offers cell therapy for genetic diseases and pharmacological drugs for genetic and age-related diseases. The company was founded by Jean-Yves Bonnefoy, Christopher Henderson, Thierry Noel, Olivier Pourquié, Marie Knockaert and Jérôme Chal on April 25, 2011 and is headquartered in Graffenstaden, France. | Health Services |
Syndivia SAS
Syndivia SAS Pharmaceuticals: MajorHealth Technology Syndivia SAS engages in the development of treatment for cancer. Its product pipeline include SDV1001, for pancreatic cancer, colorectal cancer and TNBC; and SDV1101, for breast cancer and liposarcoma. The company is headquartered in Illkirch, France. | Health Technology |
- Bolsa de valores
- Insiders
- Jean-Yves Bonnefoy